122 results
8-K
EX-4.4
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable … of a share of Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest.
Section 2. Exercise
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
the Securities Act);
(xi) a comfort letter from CohnReznick LLP (the independent registered public accounting firm of the Company), addressed to the Placement … or, to the knowledge of the Company, is imminent with respect to any of the employees, independent contractors or consultants of the Company, which
8-K
EX-10.2
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
of independent Public Company Accounting Oversight Board (PCAOB) registered public accountants for a period of at least five (5) years after the Closing Date … to be delivered to the Placement Agent, a letter from CohnReznick LLP (the independent registered public accounting firm of the Company), addressed
8-K
EX-4.2
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable … of a share of Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest.
Section 2. Exercise
8-K
EX-4.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected … reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
8-K
EX-4.5
srgrghs3
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-4.3
2vsbsbdj1 fr9a
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am